Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -1.36% vs -5.37% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 72.12% vs -79.33% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -41.64% vs -50.22% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 8.82% vs -2.86% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Harbin Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -1.36% vs -5.37% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -5.29% vs 8.54% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 72.12% vs -79.33% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -57.85% vs 45.58% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -41.64% vs -50.22% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -69.31% vs 38.36% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 8.82% vs -2.86% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -24.49% vs 5.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






